1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Cristcot HCA LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Twice daily placebo suppository administered with Sephure applicator - Ulcerative Proctitis | Phase 3 | Completed | Cristcot HCA LLC | 200 | 2020-12-10 | 2026-08-06 |
Bulgaria (1) · China (1) · Denmark (1) · France (1) · Georgia (1) · Germany (1) · India (1) · Italy (1) · Jordan (1) · Lebanon (1) · Libya (1) · Moldova (1) · Philippines (1) · Poland (1) · Romania (1)
2019 (1)